Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cyberkinetics Neurotechnology Systems
Foxborough, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The BrainGate Neural Interface System enabled severely motor-impaired individuals to control computer cursors and robotic devices using neural activity; early clinical trials demonstrated proof-of-concept in several paralyzed patients, but commercial rollout and scale-up were never achieved before company closure[1][3][5][7].
- Therapeutic areas
- OtherNeurology
- Modalities
- Device
- Industry
- Implantable Medical Devices
02
Partnerships
Brown UniversityMassachusetts General HospitalStanford UniversityCase Western Reserve UniversityEmory UniversityUniversity of California DavisVA Providence Healthcare System
Beyond the preview
Go deeper on Cyberkinetics Neurotechnology Systems.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyberkinetics Neurotechnology Systems.